Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study

Area of Science:

• Critical care medicine
• Infectious diseases
• Medical diagnostics

Background:

• Invasive pulmonary aspergillosis (IPA) poses a diagnostic challenge in critically ill patients.
• The AspICU algorithm was proposed but lacked validation in clinical practice.
• Early and accurate diagnosis of IPA is crucial for effective treatment and improved patient outcomes.

Purpose of the Study:

• To prospectively evaluate the performance of the AspICU algorithm in critically ill patients.
• To compare diagnostic accuracy between patients with positive Aspergillus cultures and those with positive galactomannan tests.
• To assess the utility of bronchoalveolar lavage fluid (BALF) galactomannan in diagnosing IPA.

Main Methods:

• Prospective observational study involving 85 critically ill patients.
• Patients were divided into positive Aspergillus culture (PAC) and only positive galactomannan (OPG) groups.
• Diagnostic workup included bronchoscopy, CT scans, and galactomannan testing in serum and BALF.

Main Results:

• BALF galactomannan levels were significantly higher in the PAC group compared to the OPG group (p < 0.001).
• No significant differences were observed in AspICU or EORTC criteria between the groups.
• Positive Aspergillus culture more strongly prompted antifungal treatment initiation than positive BALF galactomannan (88.4% vs. 59.5%, p = 0.002).

Conclusions:

• The AspICU algorithm requires further refinement for optimal IPA diagnosis in ICU settings.
• Incorporating BALF galactomannan into the AspICU algorithm could enhance diagnostic sensitivity for IPA.
• Improved diagnostic strategies are needed to guide timely antifungal therapy in critically ill patients with suspected IPA.